|
Leuprolide Clinical Trials
7 actively recruiting trials across 6 locations
Also known as: Leuprolide Depot, Leuprorelin
Pipeline
Phase 2: 4Phase 3: 3
Top Sponsors
- University of Michigan Rogel Cancer Center1
- Ohio State University Comprehensive Cancer Center1
- Novartis Pharmaceuticals1
- NRG Oncology1
- Mayo Clinic1
Indications
- Cancer7
- Heart Disease2
- Prostate Adenocarcinoma2
- Breast Cancer2
- Stage IIC Prostate Cancer AJCC v81
Birmingham, Alabama2 trials
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Central Alabama Research
Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
University of Alabama at Birmingham Cancer Center
Phase 3
Phoenix, Arizona1 trial
Atlanta, Georgia1 trial
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Emory Proton Therapy Center
Phase 3
Boston, Massachusetts1 trial
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Brigham and Women's Hospital
Phase 2
Ann Arbor, Michigan1 trial
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
University of Michigan Comprehensive Cancer Center
Phase 2
Columbus, Ohio1 trial
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Ohio State University Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.